0001348324-16-000168.txt : 20160311
0001348324-16-000168.hdr.sgml : 20160311
20160311162851
ACCESSION NUMBER: 0001348324-16-000168
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20160311
FILED AS OF DATE: 20160311
DATE AS OF CHANGE: 20160311
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: LDR HOLDING CORP
CENTRAL INDEX KEY: 0001348324
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 203933262
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 13785 RESEARCH BOULEVARD
STREET 2: SUITE 200
CITY: AUSTIN
STATE: TX
ZIP: 78750
BUSINESS PHONE: 512-344-3333
MAIL ADDRESS:
STREET 1: 13785 RESEARCH BOULEVARD
STREET 2: SUITE 200
CITY: AUSTIN
STATE: TX
ZIP: 78750
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Ross G. Joseph
CENTRAL INDEX KEY: 0001586612
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36095
FILM NUMBER: 161501106
MAIL ADDRESS:
STREET 1: C/O LDR HOLDING CORPORATION
STREET 2: 13785 RESEARCH BLVD STE 200
CITY: AUSTIN
STATE: TX
ZIP: 78750
4
1
edgardoc.xml
PRIMARY DOCUMENT
X0306
4
2016-03-11
0
0001348324
LDR HOLDING CORP
LDRH
0001586612
Ross G. Joseph
13785 RESEARCH BLVD., SUITE 200
AUSTIN
TX
78750
0
1
0
0
Exec VP Global Marketing
Common Stock
2016-03-11
4
M
0
2288.0
3.105
A
7520
D
Common Stock
2016-03-11
4
M
0
10093.0
5.94
A
17613
D
Common Stock
2016-03-11
4
S
0
17613.0
23.0731
D
0
D
Incentive Stock Option (right to buy)
3.105
2016-03-11
4
M
0
2288.0
0.0
D
2012-02-01
2020-11-19
Common Stock
2288
0
D
Incentive Stock Option (right to buy)
5.94
2016-03-11
4
M
0
10093.0
0.0
D
2013-07-10
2022-07-10
Common Stock
10093
1176
D
Includes 394 and 306 ESPP shares acquired under the LDR Holding Corporation Amended and Restated 2013 Employee Stock Purchase Plan on May 31, 2015 and November 30, 2015 respectively. Also includes 842 RSU shares acquired on 1/1/16, 1,263 RSU shares acquired on 1/16/16, and 2,427 Performance RSU shares acquired on 2/15/16.
The price indicated is the weighted average sale price for the shares sold. The individual sale price for the shares indicated range from $22.87 to $23.24. The reporting person undertakes to provide the Issuer and any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, further information regarding the number of shares sold at each separate price such shares were sold.
ISO becomes exercisable in combination with NQSO granted on the same date wherein the shares vest in forty-eight equal monthly installments from the vesting commencement date of January 1, 2012.
ISO becomes exercisable in combination with NQSO granted on the same date wherein 25% of the shares granted become exercisable upon one year from the vesting commencement date of July 10, 2012, then in thirty-six equal monthly installments thereafter.
By: Scott E. Way For: Ross G. Joseph
2016-03-11